Metavention Announces Initiation of Groundbreaking Multi-Organ Denervation Study
![]() |
MINNEAPOLIS, May 4, 2021 /PRNewswire/ -- Metavention, Inc. announces the initiation of the MODUS Study (ACTRN12620000412932), to treat patients with both type 2 diabetes and hypertension using a catheter-based, minimally invasive approach.
The first procedures in this study were successfully completed at The Alfred Hospital in Melbourne, Australia b...
Read more: Metavention Announces Initiation of Groundbreaking Multi-Organ Denervation Study